Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Chemiluminescence analyzers market in India to grow at 6% CAGR through 2033, forecasts GlobalData

Chemiluminescence immunoassay (CLIA) analyzers are indispensable tools in Indian medical landscape, offering a broad spectrum of applications encompassing infectious disease testing and cancer biomarker analysis. Consequently, they play a pivotal role in enhancing healthcare delivery, facilitating disease management, and advancing public health initiatives in the country. Against this backdrop, India’s chemiluminescence analyzers market is expected […]
Read more

Diagnostic imaging to see advances in AI, imaging agents, and ultrasound technology in 2024, says GlobalData

The surging global aging population and escalating disease prevalence, notably cancer, are propelling a heightened demand for imaging. Diagnostic imaging is undergoing a transformative R&D phase, with a focus on software, hardware, and consumables tailored for early disease diagnosis and personalized medicine applications. The recent strides in artificial intelligence (AI), imaging agents, and ultrasound technology […]
Read more

Boston Scientific may soon end Medtronic’s brief monopoly in pulsed-field ablation space, says GlobalData

In December 2023, Medtronic received FDA approval for its pulsed-field ablation (PFA) system, PulseSelect. While the PulseSelect is not the first PFA system to be marketed in the world (Boston Scientific’s Farapulse system received CE approval in 2021), it is indeed the first PFA catheter system to receive FDA approval. However, Medtronic’s success in this […]
Read more

PulseAI’s innovative AI algorithm poised to redefine cardiac health monitoring, says GlobalData

In a revolutionary stride towards advancing consumer electrocardiogram (ECG) diagnostics, Belfast-based medical technology company PulseAI unveiled a groundbreaking artificial intelligence (AI) algorithm, empowering individuals to proactively assess and understand their heart health with enhanced precision. This cutting-edge technology that combines AI with ECG data is poised to redefine the landscape of cardiac health monitoring, says […]
Read more

India coronary drug eluting stents market to register 4% CAGR through 2033, forecasts GlobalData

Already known as the heart disease capital of the world, India is seeing a growing incidence of cardiovascular diseases, especially among young adults, owing to a poor lifestyle. Driven by the growing incidence of coronary artery diseases, improved access to the latest treatment options, higher diagnosis rates, and technological advancements, the coronary drug eluting stents […]
Read more

India renal denervation catheter market to grow at 11% CAGR through 2033, forecasts GlobalData

The rising prevalence of hypertension in India has become a significant health concern, leading to serious health issues and increased mortality rates. Renal denervation has been emerging as one of the potential solutions to address these challenges, particularly for resistant hypertension. Against this background, the renal denervation catheters market in India is expected to grow […]
Read more

GlobalData highlights shift in neuromodulation devices landscape as Neuralace Medical’s Axon Therapy receives US FDA clearance

Neuralace Medical, a California-based innovator in pain management technology, has recently received the FDA clearance for its Axon Therapy, a non-invasive, magnetic peripheral nerve stimulation (mPNS) treatment for chronic painful diabetic neuropathy (PDN). The approval marks a significant turning point in the neuromodulation field. It reflects the industry’s commitment to developing innovative, patient-centric solutions that […]
Read more

FDA approval of Darmiyan BrainSee major step forward in Alzheimer’s diagnosis during awareness month, says GlobalData

January marks the start of Alzheimer’s Awareness Month, as set by the Alzheimer Society of Canada. California-based brain technology (deep-tech) company Darmiyan’s clinical brain test “BrainSee” has recently secured FDA approval. The diagnosis rates for Alzheimer’s and dementia are currently quite low, so frequent and improved diagnostic methods such as these are needed to treat […]
Read more

National Birth Defects Awareness Month highlights need for increased congenital syphilis testing in US, says GlobalData

January is observed as National Birth Defects Awareness and Prevention Month annually to raise awareness about birth defects in the US. In November 2023, the Centers for Disease Control and Prevention (CDC) issued a statement drawing attention to the steeply escalating incidence of syphilis cases in newborns in the US, indicating a 10-fold increase in […]
Read more

China reproductive health devices market to reach $450 million in 2030, forecasts GlobalData

China has been witnessing an increasing demand for various reproductive health tests and devices due to several factors such as a growing population, rising awareness about reproductive health, improving healthcare infrastructure, and changing lifestyles. Against this backdrop, China’s reproductive health devices market is expected to reach $450 million in 2030, forecasts GlobalData, a leading data […]
Read more

Bitcoin ETF approval underscores maturation of cryptocurrency space, says GlobalData

In a groundbreaking move equipped to reshape the financial industry, the Securities and Exchange Commission (SEC) has officially approved the eagerly awaited Bitcoin Exchange-Traded Fund (ETF). This historic approval underscores the maturation of the cryptocurrency space and the increasing acknowledgment of its potential as a legitimate and viable asset class, says GlobalData, a leading data […]
Read more

Integration of Abbott and Tandem devices provide new option for diabetic patients, says GlobalData

Abbott and Tandem Diabetes Care recently announced the wireless integration of Abbott’s FreeStyle Libre 2 Plus continuous glucose monitor with the Tandem t:slim X2 insulin pump in the US. This announcement provides another useful treatment option for diabetic patients requiring insulin therapy and who wish to utilize continuous glucose monitoring, says GlobalData, a leading data […]
Read more

AI and strategic partnerships to help Singapore accelerate transformation of kidney disease management, says GlobalData

Kidney failure poses a major health challenge in the Asia Pacific (APAC) region, with Singapore standing out as one of the APAC countries with a high incidence of end-stage renal disease. To address this issue, Singapore is actively working with national and international organizations to develop and implement new artificial intelligence (AI)-based models. This is […]
Read more
1 … 15 16 17 18 19 … 50